One of the representative lncRNAs, H19, is recognized as a cancer biomarker and is associated with the occurrence of esophageal cancer (98), colorectal cancer (99), liver cancer (100), breast cancer (101), bladder cancer (102), and stomach cancer. This evidence concerns the gene H19 and urinary bladder cancer.